Avonex (interferon beta-1a) is a brand-name drug prescribed to treat certain forms of multiple sclerosis (MS) in adults. It’s administered via intramuscular injection. The typical Avonex dosage starts ...
European Commission approves the first single-use intramuscular autoinjector designed to improve convenience of once-weekly AVONEX (interferon beta-1a) administration “At Biogen Idec, our commitment ...
-- First single-use intramuscular autoinjector designed to improve convenience of once-weekly AVONEX recommended for approval in the European Union and authorised in Canada -- AVONEX PEN is designed ...
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Biogen Idec Canada Inc today announced AVONEX ® PEN ™ is now available for patients with relapsing multiple sclerosis (MS) and patients with a single ...
Biogen Idec Inc. is keeping its injectable bases covered in relapsing multiple sclerosis (RMS) with the approval Friday of Plegridy (peginterferon beta-1a), given by an auto-injector pen or prefilled ...
Avonex, used to treat certain types of multiple sclerosis, can cause side effects ranging from mild, such as headaches and muscle pain, to serious, including depression and liver damage. Long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results